Skip to main content
. 2021 Jul 12;2021:1768720. doi: 10.1155/2021/1768720

Figure 13.

Figure 13

Pathological changes (HE staining, 400×): (a) blank control group; (b) model group; (c) MSHC high-dose group; (d) MSHC medium-dose group; (e) MSHC low-dose group; (f) metformin group.